BRCA1 and posterior cortical atrophy: The IMPACT study evaluated PSA screening in men with a known genetic PCa predisposition due to BRCA1/2 mutations and found that a value of PSA >3 ng/mL is more strongly predictive in BRCA carriers than noncarriers [16,88].